Loading...
935106861
info@markelab.com
Precio
375€ (100 µg)
Zolbetuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CLDN18, Zolbetuximab is under investigation in clinical trial NCT01630083 (Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18. 2-positive Gastric Cancer).
Biosimilars
Human, Mouse
Monoclonal
Human
CLDN18
Human, Mouse
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1496553-00-4
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más